![](/img/cover-not-exists.png)
Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer
Do, Khanh, Speranza, Giovanna, Bishop, Rachel, Khin, Sonny, Rubinstein, Larry, Kinders, Robert J., Datiles, Manuel, Eugeni, Michelle, Lam, Michael H., Doyle, L. Austin, Doroshow, James H., Kummar, ShiVolume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0212-z
Date:
June, 2015
File:
PDF, 1.40 MB
english, 2015